SEARCH

SEARCH BY CITATION

References

  • 1
    Saito J, Inoue K, Sugawara A, Yoshikawa M, Watanabe K, Ishida T et al. Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren. J Allergy Clin Immunol 2004;114:512516.
  • 2
    Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 2006;533:240252.
  • 3
    Sheffield M, Mabry S, Thibeault DW, Truog WE. Pulmonary nitric oxide synthases and nitrotyrosine: findings during lung development and in chronic lung disease of prematurity. Pediatrics 2006;118:10561064.
  • 4
    Belik J, Shehnaz D, Pan J, Grasemann H. Developmental changes in arginase expression and activity in the lung. Am J Physiol Lung Cell Mol Physiol 2008;294:L498L504.
  • 5
    Bergeron C, Boulet LP, Page N, Laviolette M, Zimmermann N, Rothenberg ME et al. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol 2007;119:391397.
  • 6
    Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YC. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol 1998;275:L96L102.
  • 7
    Wechsler ME, Grasemann H, Deykin A, Silverman EK, Yandava CN, Israel E et al. Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am J Respir Crit Care Med 2000;162:20432047.
  • 8
    Storm van’s Gravesande K, Wechsler ME, Grasemann H, Silverman ES, Le L, Palmer LJ et al. Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med 2003;168:228231.
  • 9
    Leung TF, Liu EK, Tang NL, Ko FW, Li CY, Lam CW et al. Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children. Clin Exp Allergy 2005;35:12881294.
  • 10
    Leung TF, Liu EK, Li CY, Chan IH, Yung E, Lam CW et al. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration. Pediatr Pulmonol 2006;41:649655.
  • 11
    Ali M, Khoo SK, Turner S, Stick S, Le Souef P, Franklin P. NOS1 polymorphism is associated with atopy but not exhaled nitric oxide levels in healthy children. Pediatr Allergy Immunol 2003;14:261265.
  • 12
    Pascual M, Sanz C, Isidoro-Garcia M, Davila I, Moreno E, Laffond E et al. (CCTTT)n polymorphism of NOS2A in nasal polyposis and asthma: a case-control study. J Investig Allergol Clin Immunol 2008;18:239244.
  • 13
    Shirai T, Inui N, Suda T, Chida K. Correlation between peripheral blood T-cell profiles and airway inflammation in atopic asthma. J Allergy Clin Immunol 2006;118:622626.
  • 14
    Leung TF, Wong GW, Ko FW, Lam CW, Fok TF. Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis. Thorax 2005;60:822826.
  • 15
    McConnell R, Berhane K, Yao L, Jerrett M, Lurmann F, Gilliland F et al. Traffic, susceptibility, and childhood asthma. Environ Health Perspect 2006;114:766772.
  • 16
    Linn WS, Berhane KT, Rappaport EB, Bastain TM, Avol EL, Gilliland FD. Relationships of online exhaled, offline exhaled, and ambient nitric oxide in an epidemiologic survey of schoolchildren. J Expo Sci Environ Epidemiol 2009;19:674681.
  • 17
    Linn WS, Rappaport EB, Berhane KT, Bastain TM, Avol EL, Gilliland FD. Exhaled nitric oxide in a population-based study of southern California schoolchildren. Respir Res 2009;10:28.
  • 18
    Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160:21042117.
  • 19
    Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE et al. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003;55:2736.
  • 20
    Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945959.
  • 21
    Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 2003;164:15671587.
  • 22
    Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes 2007;7:574578.
  • 23
    Hubisz MJ, Falush D, Stephens M, Pritchard JK. Inferring weak population structure with the assistance of sample group information. Molecular Ecology Resources 2009;9:13221332.
  • 24
    Shtir CJ, Marjoram P, Azen S, Conti DV, Le Marchand L, Haiman CA et al. Variation in genetic admixture and population structure among Latinos: the Los Angeles Latino eye study (LALES). BMC Genet 2009;10:71.
  • 25
    Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD et al. Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 2008;17:28342848.
  • 26
    Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007;31:383395.
  • 27
    Islam T, Breton C, Salam MT, McConnell R, Wenten M, Gauderman WJ et al. Role of inducible nitric oxide synthase in asthma risk and lung function growth during adolescence. Thorax 2010;65:139145.
  • 28
    Guo Z, Shao L, Du Q, Park KS, Geller DA. Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter. FASEB J 2007;21:535542.
  • 29
    Pautz A, Linker K, Altenhofer S, Heil S, Schmidt N, Art J et al. Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1. J Biol Chem 2009;284:27552766.
  • 30
    Salam MT, Islam T, Gauderman WJ, Gilliland FD. Roles of arginase variants, atopy, and ozone in childhood asthma. J Allergy Clin Immunol 2009;123:596602. 602 e591–598.
  • 31
    Vonk JM, Postma DS, Maarsingh H, Bruinenberg M, Koppelman GH, Meurs H. Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response. Pharmacogenet Genomics 2010;20:179186.
  • 32
    Lee J, Ryu H, Ferrante RJ, Morris SM Jr, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA 2003;100:48434848.
  • 33
    Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008;8:169182.